---
figid: PMC9636083__428_2022_3378_Fig1_HTML
pmcid: PMC9636083
image_filename: 428_2022_3378_Fig1_HTML.jpg
figure_link: /pmc/articles/PMC9636083/figure/Fig1/
number: Fig. 1
figure_title: ''
caption: Schematic illustration of the study design
article_title: 'Comparison of HercepTest™ mAb pharmDx (Dako Omnis, GE001) with Ventana
  PATHWAY anti-HER-2/neu (4B5) in breast cancer: correlation with HER2 amplification
  and HER2 low status.'
citation: Josef Rüschoff, et al. Virchows Arch. 2022;481(5):685-694.
year: '2022'

doi: 10.1007/s00428-022-03378-5
journal_title: Virchows Archiv
journal_nlm_ta: Virchows Arch
publisher_name: Springer Berlin Heidelberg

keywords:
- Invasive breast carcinoma
- HER2
- IHC
- FISH
- HercepTest (mAb)
- Dako Omnis
- PATHWAY 4B

---
